Biotechnology: Market Research Report

December 2011 | 281 pages | ID: B943192F018EN
Global Industry Analysts, Inc

Abstracts

The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings.

The report offers a bird’s eye view of the Biotechnology industry.

Annotated with 21 fact, and data rich tables the report offers a sneak peek into major end-use industries.

Also included is a compilation of all recent mergers, acquisitions, and strategic corporate developments.

A regional-level of discussion mirrors the prevalent scenario in key regional markets such as the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others.

The report also includes an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 1,180 companies worldwide.

Contents

1.BIOTECHNOLOGY

Global Market Overview
Global Biotechnology Industry Recovers Strongly from Recession
Current and Future Analysis

Table 1. Global Biotechnology Market by Geographic Region – US, Europe, Asia- Pacific and Rest of World with Annual Revenues in US$ million for Years 2010 through 2015

Table 2. Global Biotechnology Market (2011&2015) Percentage Breakdown of Value Sales by Geographic Region – US, Europe, Asia-Pacific and Rest of World

Table 3. Global Biotechnology Market by Product Application – Medical (Therapeutics, Diagnostics and Other Medical Biotech Applications), Biotech Services and Other Biotech Applications with Annual Revenues in US$ million for Years 2010 through 2015

Table 4. Global Biotechnology Market (2011 & 2015): Percentage Breakdown of Value Sales by Product Application – Medical (Therapeutics, Diagnostics and Other Medical Biotech Applications), Biotech Services and Other Biotech Applications

Table 5. Global Biotechnology Industry (2010): Percentage Breakdown by Funding Type – Public Offering, Venture Funding & Others

Table 6. Leading Countries in Terms of Mergers and Acquisitions in the Biotech Space (2010)

Market for “Follow-On” Biologics
Marine Biotechnology
Major Trends
Developing Countries to Emerge as Major Biotech Hubs
Application of Biotechnology Techniques to Rise Tremendously
Biotech Acquisitions Get More Focused
Major M&A Activities
Contract Manufacturing – A New Business Motto for Biotechnology Companies
Oncology Dominates Biotech Drugs Sale
Investment on Research: Vital for the Survival of Biotech Companies
Asia-Pacific: A Promising Market for Biopharmaceutical Companies
Biotech Regenerative Medicine Catching On
Reverse Merger Transactions Characterizes the Asian Biotech Sector
Biotech Instrumentation to Speed Up Biotech Research Process
Growth of Bioventure Startups in Japan
Advent of “Mid-Tier” Companies in the Biotech Market
Biogenerics Poised for a Big Entry
Development of DNA Vaccines
Issues Related to Pricing and Reimbursement of Biotech Drugs
End-Use Industries
Overview of Agricultural and Food Biotechnology

Table 7. Acreage of Biotech Crops in US, Argentina, India, Canada, China, Paraguay, Bolivia, Uruguay, Australia, Mexico and Others (2009)

Plants Based Drugs – Innovative Agri Biotech Products
Consolidated Trends
Animal Husbandry and Veterinary Science
Outlook of Health and Medical Biotechnology
Biotech Technologies/Fields of Medical & Health Sector
Bioinformatics
Genomics
Pharmacogenomics
Proteomics
Biochips
Overview of the Biochip Industry
Biochip Technology
Tech Giants Join the Biochip Fray
Biologic Drugs
Cell and Tissue Culture
Market Overview
Proteomics and Pharmacokinetics Drive Market Growth
Regulations Prompt Change in Trends
Biotechnology Instruments
Market Overview
Innovations and Discoveries – Fuel Demand for Biotech Instrumentation
Biotechnology Reagents
Market Overview
Highly Automated Instrumentation Restricts Use of Reagents
Molecular Biology and Protein Synthesis Reagents are Growing Rapidly

2.MERGERS AND ACQUISITIONS

3.STRATEGIC CORPORATE DEVELOPMENTS

4.PRODUCT LAUNCHES & DEVELOPMENTS

A REGIONAL MARKET PERSPECTIVE

1.NORTH AMERICA

1A.THE UNITED STATES

Overview

Table 8. Fundings for US Biotechnology Industry in 2010

Demand for Biochips to Grow Strongly
Agricultural Biotechnology
Cultivation of GM Crops Rises in US
Biologics – Market Overview
Medical Biotechnology – Market Overview

Table 9. US Pharmaceutical Industry (1996-2010): Number of Drugs Approved by US FDA

Table 10. US Pharmaceutical Industry (2010): Percentage Breakdown of Drug Sales by Type – Generic and Prescription

Table 11. US Healthcare Industry: Projected Expenditure on Healthcare as % of GDP

Table 12. US Pharmaceutical Industry (2010): Top Four Drug Development Biotechnology Companies by Revenues

Table 13. US Pharmaceutical Industry (2010): Percentage Share Breakdown Number of Pipeline Drugs by Indication

Bioinformatics
Proteomics
Biochips
Challenges Faced by US Biotechnology Market

1B.CANADA

Market Overview
Revenues and R&D Expenditures Plunge

Table 14. Canadian Biotechnology Industry (2010): Funds Raised by Biotechnology Clusters

1C.MEXICO

End-Use Industries
Bio-Pharmaceuticals
Food Biotechnology
Environmental Biotechnology

2.JAPAN

Biotechnology Market Overview
Japanese Companies Expand Business Operations
End-Use Industries
Medical Biotechnology and Healthcare
Biosimilars
Food Biotechnology Industry
Environmental Biotechnology

3.EUROPE

Industry Overview

Table 15. European Biotechnology Industry (2010): Number of Biotechnology Product Candidates by Country

Finance Scenario

Table 16. VC Fundings in US and Europe (2010): Percentage Share Breakdown by Indication

Regulatory and Policy Landscape
Current & Future Analysis

Table 17. European Biotechnology Market by Country/Region – France, Germany, Italy, UK, Spain and Rest of Europe – With Annual Revenues in US$Million for Years 2010 through 2015

Table 18. European Biotechnology Market (2011 & 2015): Percentage Breakdown of Value Sales by Country/Region

Table 19. Number of Public Biotechnology Companies in Europe by Country (2010)

3A.DENMARK

3B.FRANCE

Overview
French Government Takes Active Measures to Boost Financing
Challenges and Outlook

3C.GERMANY

Overview
Government Support

3D.ITALY

Overview

3E.THE NETHERLANDS

Market Prospects

3F.POLAND

Overview
Market Access Regulations

3G.UNITED KINGDOM

Agricultural Biotechnology
Impact of Financial Crisis and Outlook

3H.SWEDEN

Overview

3I.SWITZERLAND

Overview

3J.SPAIN

4.ASIA-PACIFIC

Overview

4A.AUSTRALIA

Overview

4B.NEW ZEALAND

Overview
Biotech Companies Attract
Investments from Asia
Government Support

4C.CHINA

Pharmaceutical Segment Dominates Chinese Biotech Market

Table 20. Chinese Biopharmaceutical Market (2010): Funds Raised by IPOs

4D.INDIA

Market Overview

Table 21. Indian Biotechnology Market (2010): Percentage Breakdown of Value Sales by Segment - Biopharma, Bioagri, Bioservices, Bioindustry and Bioinformatics

Booming Biotechnology Industry
Exports – A Major Market for Indian Biotech Industry
Bioinformatics Market to Grow Exponentially in India
Bio-pharma Drives Growth in Biotech Industry
Overview of the Biosimilars Sector
Personalized Medicine – An Emerging Field
A Growing Hub for Clinical Trials and R&D
M&A Scenario Remains Strong
Select Corporate Developments in India (2010)
Transformation - Creating a Platform for Future Growth in Biotech Industry
Regulatory Environment in India
Challenges

4E.MALAYSIA

Overview of Malaysian Biotechnology Industry
Role of National Biotechnology Directorate (Biotek)

4F.SOUTH KOREA

Biotechnology Industry Overview

4G.TAIWAN

4H.SINGAPORE

Overview
Singapore Biotech Start-ups Face Funding Challenges

5.OTHER MARKETS

5A.ARGENTINA

5B.BRAZIL

Industry Outlook
Government Support Spurs Biotech Industry
End-Use Industries
Diagnostics
Biopharmaceuticals
Biotechnology and Animal Health
Agricultural Biotechnology
Environmental Biotechnology
Biotechnology in Food Processing

5C.ISRAEL

Global Directory